Acadia Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
ALKERMES USD 1.77M 4K 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Corcept Therapeutics USD 136K 1000 2024-12
Cytokinetics USD 118K 0 2024-12
Eisai JPY 44.99B 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Incyte USD 193K 1000 2024-12
Intra Cellular Therapies USD 11K 0 2024-12
J&J USD 3.12B 0 2024-12
Moderna USD 38.6K 100 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Pfizer USD 480M 0 2024-12
Prothena USD 538K 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Sarepta Therapeutics USD 10K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Acadia Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.